Financhill
Back

Gilead Sciences 10K Form

Sell
39

GILD
Gilead Sciences

Last Price:
73.55
Seasonality Move:
5.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $2.54B
Price / Cash Flow: 11.56
Annual Sales: $18.26
Price / Book: 4.03

Profitability

EPS (TTM): 4.50000
Net Income (TTM): $5.66B
Gross Margin: $20.62B
Return on Equity: 26.17%
Return on Assets: 9.08%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.46
Quick Ratio: 1.16

Price-to-Earnings

Trailing P/E Ratio: 16.34
Forward P/E Ratio: 9.88

GILD Technical Analysis vs Fundamental Analysis

Sell
39
Gilead Sciences (GILD) is a Sell

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Sell
    The current Gilead Sciences [GILD] share price is $73.55. The Score for GILD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.